Your body is not a snapshot.
ENDARIA connects every signal you already have, your blood tests, wearables, symptoms and treatment, into one longitudinal picture. Bring every signal. See one pattern.
Bring every signal. See one pattern.
Everyone else is racing to build the one sensor. ENDARIA is the intelligence layer that sits above them. It doesn't matter where your data comes from, ENDARIA turns it into one longitudinal picture your clinician can read, and it only gets richer over time.
Bring your data
See one picture
One signal rarely tells the whole story. Connected, over time, they begin to.
This is a preview of the ENDARIA view, physiology, symptoms and hormone information read together, not as isolated moments.
Your last 90 days
From scattered signals to a story you can act on.
Watch how a month of small, disconnected changes becomes a single, legible pattern, the difference between "I think it got worse" and a clear record you can bring to your clinician.
Your body is already sending signals.
Sleep, temperature, heart rate patterns and symptoms, gathered quietly in the background.
"Possible vasomotor event, 2:14 am."
ENDARIA flags probable events and learns from your confirmation, becoming personal to you.
Signals read together, over time.
Sleep, symptoms, hormones and treatment on one timeline, associations, not false certainty.
Walk in with the last 90 days.
A clear summary your clinician can read, so the conversation starts with facts, not memory.
What if your next appointment started with the last 90 days?
ENDARIA generates a structured summary that organises symptoms, sleep, treatment and hormone information, built to support clinical judgement, never to replace it.
Measure. Connect. Explain. Prepare.
Measure over time
A physiological wearable and optional home testing capture what a single test can't, change, continuously.
Connect the signals
Hormones, sleep, temperature, cognition, mood and treatment, read together, with associations made honest.
Prepare your visit
A clear, shareable 90 day summary so appointments start with facts instead of trying to remember.
One idea, built in stages.
ENDARIA is the intelligence layer. LAB and SIGNAL are your own data sources that plug into it over time, not a bet on one device working on day one.
The device agnostic intelligence layer. Bring any data, blood tests, wearables, home tests, symptoms and treatment, and see one longitudinal picture.
A future wearable for longitudinal hormone measurement, built as the sensing science matures.
Portable hormone testing, so a single result is never the whole story.
The platform for clinicians that organises longitudinal information between appointments.
The research and life sciences platform, for longitudinal hormone research, treatment response studies and pharmaceutical partnerships. Menopause is the first market; female hormonal health is the platform.
Where this is heading.
Hope is building ENDARIA with a longer plan in view. When she is in a position to give at scale, she intends to found HOPE, Help One Person Every Day: safety education written for children who communicate differently, and training for the adults who care for them, given freely to anyone who can use it.
HOPE is a future charity. It is not registered, and ENDARIA does not collect donations for it.
Read what HOPE will be →Menopause is not a phase that passes. It sets a trajectory.
The transition is short, and much of what happens in it is permanent. It is also the point at which most women are told to wait and see.
Bone loss accelerates before the last period.
Bone density starts falling about a year before the final menstrual period and keeps falling into early postmenopause. Women who lose more bone in the transition have more fractures afterwards.
Cardiovascular health deteriorates faster across the transition.
Risk factors worsen through the menopause transition rather than drifting with age alone, which is why midlife is named as a critical stage for prevention.
You only know you were in the window afterwards.
The final menstrual period is confirmed twelve months late, by definition. A continuous record is the only way to see the transition while it is still happening.
Study of Women's Health Across the Nation, a longitudinal cohort running since the 1990s, and the American Heart Association scientific statement on the menopause transition and cardiovascular disease risk. ENDARIA organises information for you and your clinician. It does not prevent, diagnose or treat any condition.
A large, underserved market with real momentum.
Indicative third party estimates (Silicon Valley Bank, Dealroom, FP Analytics, Australian Government 2025 to 2026 Budget). Menopause is one of the most active femtech subsectors. Disclosed women's health exits since 2000 total more than 100 billion United States dollars, and most of that value sits in diagnostics, biopharma and devices.
Built on where the evidence actually is.
ENDARIA is designed to be scientifically responsible, it shows patterns and associations, and never claims certainty the science can't yet support. It also answers a real gap, only about one in five United States obstetrics and gynaecology residency programmes reported offering formal menopause training.
No single test defines the stage.
Hormones fluctuate through perimenopause; a single result often can't clarify the picture. So ENDARIA sells the pattern, not one number.
Continuous hormone sensing is coming.
From Caltech's oestradiol sensor that reads sweat to a Melbourne microneedle patch built with the University of Melbourne and Monash IVF, designed first for fertility care with menopause named as a next application, the science is moving fast.
Transparent by default.
Every insight distinguishes measurement from estimate, association from conclusion. Explainable, not a black box.
The things women ask us first.
No. ENDARIA helps you see and organise patterns over time and prepare for conversations with your clinician. It supports clinical judgement, it doesn't replace it, and it won't claim a diagnosis from a single reading.
The first product connects symptoms, sleep, temperature, heart rate patterns, activity, cognition, mood, treatment and optional home hormone information. Continuous hormone sensing (ENDARIA SIGNAL) is on the roadmap.
Privacy is built in from the start, not buried in a footer. Your data is yours, with explicit consent, clear controls, and no selling of your information as a hidden product.
We're onboarding The First 1,000 now, early access, research updates and a hand in shaping the product. Join below to claim a place.
Help build what should already exist.
Join the first 1,000 women shaping the future of women's health, early access, research updates, and a hand in what ENDARIA becomes.
Building the continuous hormone intelligence layer for women's health.
ENDARIA HEALTH is developing a staged platform: longitudinal health intelligence, physiological monitoring, portable biochemical testing, and future continuous hormone sensing. Menopause is the first market. Female hormonal health is the larger platform.
- A priced round at the pre seed stage is open now, alongside grant and research partnership applications. Funding of that kind extends the runway; it does not replace the round.
- A moat built from longitudinal data and clinical evidence, with anything genuinely novel protected before it is disclosed.
- Category timing: public funding for menopause care has stepped up, and wearable hormone sensing is moving from the lab to first human studies.
ENDARIA is a venture of the School of Sexual Wellness. The round is raised at umbrella level, across the group, rather than in ENDARIA alone.
Request the investor materials
Register your interest and we'll follow up with the deck and a data room invitation.